159 related articles for article (PubMed ID: 12426945)
41. Hyperthermia mediated liposomal drug delivery.
Ponce AM; Vujaskovic Z; Yuan F; Needham D; Dewhirst MW
Int J Hyperthermia; 2006 May; 22(3):205-13. PubMed ID: 16754340
[TBL] [Abstract][Full Text] [Related]
42. Liposomal drugs dispersed in hydrogels. Effect of liposome, drug and gel properties on drug release kinetics.
Mourtas S; Fotopoulou S; Duraj S; Sfika V; Tsakiroglou C; Antimisiaris SG
Colloids Surf B Biointerfaces; 2007 Apr; 55(2):212-21. PubMed ID: 17223020
[TBL] [Abstract][Full Text] [Related]
43. A fusogenic segment of glycoprotein H from herpes simplex virus enhances transfection efficiency of cationic liposomes.
Tu Y; Kim JS
J Gene Med; 2008 Jun; 10(6):646-54. PubMed ID: 18383507
[TBL] [Abstract][Full Text] [Related]
44. Correlations between the rate of intracellular release of endocytosed liposomal Doxorubicin and cytotoxicity as determined by a new assay.
Kirchmeier MJ; Ishida T; Chevrette J; Allen TM
J Liposome Res; 2001; 11(1):15-29. PubMed ID: 19530916
[TBL] [Abstract][Full Text] [Related]
45. Potential of polysaccharide anchored liposomes in drug delivery, targeting and immunization.
Sihorkar V; Vyas SP
J Pharm Pharm Sci; 2001; 4(2):138-58. PubMed ID: 11466172
[TBL] [Abstract][Full Text] [Related]
46. Formulation of photocleavable liposomes and the mechanism of their content release.
Chandra B; Subramaniam R; Mallik S; Srivastava DK
Org Biomol Chem; 2006 May; 4(9):1730-40. PubMed ID: 16633565
[TBL] [Abstract][Full Text] [Related]
47. Gene therapy progress and prospects: nonviral vectors.
Niidome T; Huang L
Gene Ther; 2002 Dec; 9(24):1647-52. PubMed ID: 12457277
[TBL] [Abstract][Full Text] [Related]
48. Preparation of pH-sensitive poly(glycidol) derivatives with varying hydrophobicities: their ability to sensitize stable liposomes to pH.
Sakaguchi N; Kojima C; Harada A; Kono K
Bioconjug Chem; 2008 May; 19(5):1040-8. PubMed ID: 18419148
[TBL] [Abstract][Full Text] [Related]
49. Photochemical drug and gene delivery.
Berg K; Selbo PK; Prasmickaite L; Høgset A
Curr Opin Mol Ther; 2004 Jun; 6(3):279-87. PubMed ID: 15264430
[TBL] [Abstract][Full Text] [Related]
50. Cationic liposome (DC-Chol/DOPE=1:2) and a modified ethanol injection method to prepare liposomes, increased gene expression.
Maitani Y; Igarashi S; Sato M; Hattori Y
Int J Pharm; 2007 Sep; 342(1-2):33-9. PubMed ID: 17566677
[TBL] [Abstract][Full Text] [Related]
51. PR_b-targeted PEGylated liposomes for prostate cancer therapy.
Demirgöz D; Garg A; Kokkoli E
Langmuir; 2008 Dec; 24(23):13518-24. PubMed ID: 18954096
[TBL] [Abstract][Full Text] [Related]
52. Layersome: development and optimization of stable liposomes as drug delivery system.
Ciobanu M; Heurtault B; Schultz P; Ruhlmann C; Muller CD; Frisch B
Int J Pharm; 2007 Nov; 344(1-2):154-7. PubMed ID: 17616287
[TBL] [Abstract][Full Text] [Related]
53. Targeted liposomal c-myc antisense oligodeoxynucleotides induce apoptosis and inhibit tumor growth and metastases in human melanoma models.
Pastorino F; Brignole C; Marimpietri D; Pagnan G; Morando A; Ribatti D; Semple SC; Gambini C; Allen TM; Ponzoni M
Clin Cancer Res; 2003 Oct; 9(12):4595-605. PubMed ID: 14555535
[TBL] [Abstract][Full Text] [Related]
54. Enhanced depigmenting effects of N-glycosylation inhibitors delivered by pH-sensitive liposomes into HM3KO melanoma cells.
Park JY; Choi H; Hwang JS; Kim J; Chang IS
J Cosmet Sci; 2008; 59(2):139-50. PubMed ID: 18408871
[TBL] [Abstract][Full Text] [Related]
55. Low-pH-sensitive poly(ethylene glycol) (PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery.
Li W; Huang Z; MacKay JA; Grube S; Szoka FC
J Gene Med; 2005 Jan; 7(1):67-79. PubMed ID: 15515149
[TBL] [Abstract][Full Text] [Related]
56. On the formulation of pH-sensitive liposomes with long circulation times.
Simões S; Moreira JN; Fonseca C; Düzgüneş N; de Lima MC
Adv Drug Deliv Rev; 2004 Apr; 56(7):947-65. PubMed ID: 15066754
[TBL] [Abstract][Full Text] [Related]
57. Special feature: A survey of the recent patent literature on the delivery of genes and oligonucleotides.
Mrsny RJ
J Drug Target; 1999; 7(1):1-10. PubMed ID: 10614811
[No Abstract] [Full Text] [Related]
58. Weakly acidic pH-responsive liposomal content release induced by histidine-modified agents.
Kashiwada A; Taoka N; Chijimi Y; Noguchi K; Shigematsu K; Miura M; Suzuki T
Org Biomol Chem; 2024 Apr; 22(14):2844-2850. PubMed ID: 38516851
[TBL] [Abstract][Full Text] [Related]
59. A review of mechanistic insight and application of pH-sensitive liposomes in drug delivery.
Paliwal SR; Paliwal R; Vyas SP
Drug Deliv; 2015 May; 22(3):231-42. PubMed ID: 24524308
[TBL] [Abstract][Full Text] [Related]
60. Preparation of pH-sensitive anionic liposomes designed for drug delivery system (DDS) application.
Aoki A; Akaboshi H; Ogura T; Aikawa T; Kondo T; Tobori N; Yuasa M
J Oleo Sci; 2015; 64(2):233-42. PubMed ID: 25748383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
